Basic Information
RNALocate ID: RLID:11002371
RNA Symbol: hsa-miR-301a-3p
Localization: Extracellular vesicle
RNA Information
RNA Name: hsa-miR-301a-3p
RNA ID: miRBase:MIMAT0000688
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 32498409
Tissue/Cell Line: Plasma
Method: qRT-PCR

Originally published in Cancers (Basel). Dias F, et al, 2020. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)
Description: Focusing on the patients from Group A, we observed that the levels of EV-derived hsa-miR-25-3p (p = 0.003), hsa-miR-126-5p (p < 0.001), hsa-miR-200c-3p (p < 0.001) and hsa-miR-301a-3p (p = 0.006) decreased after surgery (Figure 2A-C,E).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001991 Cytoplasm Cell line (HeLa) 21695135
RLID:01001992 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001993 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001994 Nucleus Colon adenocarcinoma cells 20864815
RLID:11002364 Exosome Serum 18589210
RLID:11002365 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002366 Exosome Renal cancer cells 21670082
RLID:11002367 Exosome Brain tissue 23382797
RLID:11002368 Exosome Plasma 23663360
RLID:11002369 Exosome Human mast cell line (HMC-1) 24009880
RLID:11002370 Exosome Breast cancer cell lines (MCF-7|MDA-MB-231) 24468161
RLID-D:11000112 Exosome Endothelial cells|Mast cells
RLID-D:11000400 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-301a-3p Oral squamous cell carcinoma MNDR-E-MI-35721
MNDR hsa-miR-301a-3p Large cell neuroendocrine cancer MNDR-E-MI-35722
MNDR hsa-miR-301a-3p Follicular lymphoma MNDR-E-MI-35723
MNDR hsa-miR-301a-3p Small intestinal neuroendocrine tumor MNDR-E-MI-35724
MNDR hsa-miR-301a-3p High-grade serous ovarian carcinoma MNDR-E-MI-35725
MNDR hsa-miR-301a-3p Uterine corpus endometrial carcinoma MNDR-E-MI-35726
MNDR hsa-miR-301a-3p Lymphoma MNDR-E-MI-35727
MNDR hsa-miR-301a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-35728
MNDR hsa-miR-301a-3p Estrogen-receptor negative breast cancer MNDR-E-MI-35729
MNDR hsa-miR-301a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-35730
MNDR hsa-miR-301a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-35731
MNDR hsa-miR-301a-3p Her2-receptor positive breast cancer MNDR-E-MI-35732
MNDR hsa-miR-301a-3p Breast cancer luminal MNDR-E-MI-35733
MNDR hsa-miR-301a-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-35734
MNDR hsa-miR-301a-3p Small intestine cancer MNDR-E-MI-35735
MNDR hsa-miR-301a-3p Prostate cancer MNDR-E-MI-35736
MNDR hsa-miR-301a-3p Gastric cancer MNDR-E-MI-35737
MNDR hsa-miR-301a-3p Gastric lymphoma MNDR-E-MI-35738
MNDR hsa-miR-301a-3p Alzheimer disease MNDR-E-MI-35739
MNDR hsa-miR-301a-3p Intracranial aneurysm MNDR-E-MI-35740
MNDR hsa-miR-301a-3p Esophageal carcinoma MNDR-E-MI-35741
MNDR hsa-miR-301a-3p Dysautonomia familial MNDR-E-MI-35742
MNDR hsa-miR-301a-3p Seizures MNDR-E-MI-35743
MNDR hsa-miR-301a-3p Head and neck cancer MNDR-E-MI-35744
MNDR hsa-miR-301a-3p Vogt-koyanagi-harada disease MNDR-E-MI-35745
MNDR hsa-miR-301a-3p Leukemia MNDR-E-MI-35746
MNDR hsa-miR-301a-3p Cardiovascular disease MNDR-E-MI-35747
MNDR hsa-miR-301a-3p Lung cancer MNDR-E-MI-35748
MNDR hsa-miR-301a-3p Parkinson disease MNDR-E-MI-35749
MNDR hsa-miR-301a-3p Basal-like breast cancer MNDR-E-MI-35750
MNDR hsa-miR-301a-3p Thyroid cancer MNDR-E-MI-35751
MNDR hsa-miR-301a-3p Pancreatic cancer MNDR-E-MI-35752
MNDR hsa-miR-301a-3p Melanoma MNDR-E-MI-35753
MNDR hsa-miR-301a-3p Rectum adenocarcinoma MNDR-E-MI-35754
MNDR hsa-miR-301a-3p Nephroblastoma MNDR-E-MI-35755
MNDR hsa-miR-301a-3p Colon cancer MNDR-E-MI-35756
MNDR hsa-miR-301a-3p Colon adenocarcinoma MNDR-E-MI-35757
MNDR hsa-miR-301a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-35758
MNDR hsa-miR-301a-3p Familial ovarian cancer MNDR-E-MI-35759
MNDR hsa-miR-301a-3p Laryngeal squamous cell carcinoma MNDR-E-MI-35760
MNDR hsa-miR-301a-3p Carcinoma ductal breast MNDR-E-MI-35761
MNDR hsa-miR-301a-3p Glioblastoma MNDR-E-MI-35762
MNDR hsa-miR-301a-3p Glioma MNDR-E-MI-35763
MNDR hsa-miR-301a-3p Central nervous system lymphoma MNDR-E-MI-35764
MNDR hsa-miR-301a-3p Amyotrophic lateral sclerosis MNDR-E-MI-35765
MNDR hsa-miR-301a-3p Epilepsy temporal lobe MNDR-E-MI-35766
MNDR hsa-miR-301a-3p Osteosarcoma MNDR-E-MI-35767
MNDR hsa-miR-301a-3p Liposarcoma MNDR-E-MI-35768
MNDR hsa-miR-301a-3p Breast carcinoma MNDR-E-MI-35769
MNDR hsa-miR-301a-3p Uterine cancer MNDR-E-MI-35770
MNDR hsa-miR-301a-3p Gastric adenocarcinoma MNDR-E-MI-35771
MNDR hsa-miR-301a-3p Cervical squamous cell carcinoma MNDR-E-MI-35772
MNDR hsa-miR-301a-3p Lung squamous cell carcinoma MNDR-E-MI-35773
MNDR hsa-miR-301a-3p Non-small cell lung adenocarcinoma MNDR-E-MI-35774
MNDR hsa-miR-301a-3p Lung adenocarcinoma MNDR-E-MI-35775
MNDR hsa-miR-301a-3p Adrenocortical cancer MNDR-E-MI-35776
MNDR hsa-miR-301a-3p Ovarian carcinoma MNDR-E-MI-35777
MNDR hsa-miR-301a-3p Bladder urothelial carcinoma MNDR-E-MI-35778
MNDR hsa-miR-301a-3p Pancreatic adenocarcinoma MNDR-E-MI-35779
MNDR hsa-miR-301a-3p Carcinoma renal cell MNDR-E-MI-35780
MNDR hsa-miR-301a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-35781
MNDR hsa-miR-301a-3p Clear cell renal cell carcinoma MNDR-E-MI-35782
MNDR hsa-miR-301a-3p Cholangiocarcinoma MNDR-E-MI-35783
MNDR hsa-miR-301a-3p Esophageal cancer MNDR-E-MI-35784
MNDR hsa-miR-301a-3p Lung small cell carcinoma MNDR-E-MI-35785
MNDR hsa-miR-301a-3p Synovial sarcoma MNDR-E-MI-35786
MNDR hsa-miR-301a-3p Head and neck squamous cell carcinoma MNDR-E-MI-35787
MNDR hsa-miR-301a-3p Testicular germ cell cancer MNDR-E-MI-35788
MNDR hsa-miR-301a-3p Fibromyalgia MNDR-E-MI-35789
MNDR hsa-miR-301a-3p Pulmonary hypertension MNDR-E-MI-35790
MNDR hsa-miR-301a-3p Breast invasive carcinoma MNDR-E-MI-35791
MNDR hsa-miR-301a-3p Hepatocellular carcinoma MNDR-E-MI-35792
MNDR hsa-miR-301a-3p Familiar ovarian carcinoma MNDR-E-MI-35793
MNDR hsa-miR-301a-3p Rheumatoid arthritis MNDR-E-MI-35794
MNDR hsa-miR-301a-3p T-cell leukemia MNDR-E-MI-35795
MNDR hsa-miR-301a-3p Malignant pleural mesothelioma MNDR-E-MI-35796
MNDR hsa-miR-301a-3p Retinoblastoma MNDR-E-MI-35797
MNDR hsa-miR-301a-3p Hodgkin lymphoma MNDR-E-MI-35798
MNDR hsa-miR-301a-3p Tonsil cancer MNDR-E-MI-35799
MNDR hsa-miR-301a-3p Colorectal cancer MNDR-E-MI-35800
MNDR hsa-miR-301a-3p Nasopharynx carcinoma MNDR-E-MI-35801
MNDR hsa-miR-301a-3p Multiple myeloma MNDR-E-MI-35802
MNDR hsa-miR-301a-3p Acute lymphocytic leukemia MNDR-E-MI-35803
MNDR hsa-miR-301a-3p Ependymoma MNDR-E-MI-35804
MNDR hsa-miR-301a-3p Nasopharyngeal cancer MNDR-E-MI-35805
MNDR hsa-miR-301a-3p Prostatic neoplasms MNDR-E-MI-35806
MNDR hsa-miR-301a-3p Subarachnoid hemorrhage traumatic MNDR-E-MI-35807
MNDR hsa-miR-301a-3p Venous thromboembolism MNDR-E-MI-35808
MNDR hsa-miR-301a-3p Chronic pain MNDR-E-MI-35809
MNDR hsa-miR-301a-3p Stroke lacunar MNDR-E-MI-35810
MNDR hsa-miR-301a-3p Breast cancer her3+ negative MNDR-E-MI-35811
MNDR hsa-miR-301a-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-35812
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ADCY3 Homo sapiens RR00044354
TOP